Compounds > 6-bromoandrostenedione
Page last updated: 2024-11-08

6-bromoandrostenedione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-bromoandrostenedione: RN given refers to (6beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID161972
SCHEMBL ID9017837
MeSH IDM0084246

Synonyms (25)

Synonym
38632-00-7
6-bromoandrostenedione
(6r,8r,9s,10r,13s,14s)-6-bromo-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-3,17-dione
rjeyowudt6 ,
androst-4-ene-3,17-dione, 6-bromo-, (6beta)-
unii-rjeyowudt6
AKOS015903508
6b-bromoandrost-4-ene-3,17-dione
SCHEMBL9017837
androst-4-ene-3,17-dione, 6-bromo-, (6.beta.)-
(3as,3br,5r,9ar,9bs,11as)-5-bromo-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthrene-1,7-dione
AS-64937
6.beta.-bromoandrostenedione
(6.beta.)-6-bromoandrost-4-ene-3,17-dione
androst-4-ene-3,17-dione, 6.beta.-bromo-
6.beta.-bromoandrost-4-ene-3,17-dione
CS-0036986
6-bromo androstenedione
6beta-bromo androstenedione
androst-4-ene-3,17-dione, 6-bromo-, (6b)-
D72614
(6beta)-6-bromoandrost-4-ene-3,17-dione
DTXSID10959474
6-bromoandrost-4-ene-3,17-dione
6?-bromo androstenedione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.98 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
aminoglutethimide
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.. aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.		1.9610dicarboximide;
piperidones;
substituted aniline		adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
estrone
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.		1.951017-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols		antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
androstenedione
Androstenedione: A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.. androst-4-ene-3,17-dione : A 3-oxo Delta(4)-steroid that is androst-4-ene substituted by oxo groups at positions 3 and 17. It is a steroid hormone synthesized in the adrenal glands and gonads.		3.065017-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
formestane
[no description available]		1.961017-oxo steroid;
3-oxo-Delta(4) steroid;
enol;
hydroxy steroid		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
testolactone
Testolactone: An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.		2.36203-oxo-Delta(1),Delta(4)-steroid;
seco-androstane
4-acetoxy-4-androstene-3,17-dione
4-acetoxy-4-androstene-3,17-dione: aromatase (estrogen synthetase) inhibitor		1.9610
androsta-1,4,6-triene-3,17-dione
androsta-1,4,6-triene-3,17-dione: blocks aromatization of testosterone to estradiol; aromatase antagonist. androsta-1,4,6-triene-3,17-dione : An androstanoid that is androsta-1,4,6-triene substituted by oxo groups at positions 3 and 17.		1.961017-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
androstanoid		EC 1.14.14.14 (aromatase) inhibitor;
human xenobiotic metabolite
testololactone
[no description available]		2.36203-oxo-Delta(4) steroid;
seco-androstane;
steroid lactone
nadp
[no description available]		1.9710
ConditionIndicatedRelationship StrengthStudiesTrials
Breast Cancer
[description not available]		02.6530
Breast Neoplasms
Tumors or cancer of the human BREAST.		02.6530
Pregnancy
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.		02.3720
Local Neoplasm Recurrence
[description not available]		01.9610